Virscio is a specialty translational research organization developing and providing innovative in vivo disease modeling and related preclinical research and development services to meet the preclinical, translational, and regulatory research needs of the pharmaceutical and life sciences industry. We specialize in the fields of ophthalmology, central nervous system, cardiovascular and metabolic related disease and disorders, and have advanced discovery and development programs for a wide range of sponsors, collaborators, and partners around the world, ranging from large pharmaceutical companies and venture-backed biotechnology companies to academic teams seeking to apply the most cutting edge research and development strategies in the most efficient and robust manner.
Looking for a particular Virscio employee's phone or email?
Virscio Questions
The Virscio annual revenue was $16.8 million in 2026.
Matthew Lawrence is the CEO and CSO of Virscio.
51 people are employed at Virscio.
Virscio is based in New Haven, Connecticut.
The NAICS codes for Virscio are [5417, 54, 541714, 541, 54171].
The SIC codes for Virscio are [87, 873].
Top Virscio Employees
-
Matthew Lawrence
CEO and CSO at Virscio
New Haven, CT, US24 -
Christopher Stanley
Chief Business Officer, Co-Founder, Director at Virscio
Los Angeles, CA, US13 -
Jeanne Damon
Head of People and HR Operations at Virscio
Philadelphia, PA, US33 -
Carrie Panepinto
Director Business Development at Virscio
Boston, MA, US25 -
Joseph MacHi
Director Computer Systems Validation at Virscio
New York, NY, US15+ -
Igor Mikaelian
Senior Director, Pathology at Virscio
Cambridge, MA, US22 -
Bibiana Iglesias
Associate Director Ophthalmic Research at Virscio
Tarrytown, NY, US22 -
Ben Culp
Director of Research Operations at Virscio
Saint Kitts and Nevis22 -
Stephen Tarasek
Proposal and Contract Manager at Virscio
Rochester, NY, US11 -
Richard Bouffard
Histology Director at Virscio
Connecticut, United States21
Related Companies
